Board MeetingAug 4, 2026, 04:04 PM
Spero Therapeutics Q2 2026 Earnings Call Scheduled for August 12
AI Summary
Spero Therapeutics, Inc. announced it will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 12, 2026, after market close. Following the release, management will host a conference call and live audio webcast at 5:00 pm EDT to discuss the results and provide a business and pipeline update. The webcast will be available on the company's investor relations page.
Key Highlights
- Spero Therapeutics to report Q2 2026 financial results on Wednesday, August 12, 2026.
- Results will be released after market close.
- Management will host a conference call and live audio webcast at 5:00 pm EDT.
- The call will discuss results and provide a business and pipeline update.
- Conference ID for the call is 13762082.
Price Impact
More from SPRO